Ascend Wellness Holdings (AAWH) Other Non-Current Assets (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Other Non-Current Assets came in at $11.3 million in Q1 2026, down 26.97% year-on-year from $15.5 million in Q1 2025, and down 24.54% quarter-over-quarter from $15.0 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $11.3 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 26.97% year-over-year to $11.3 million in Q1 2026; TTM through Mar 2026 was $11.3 million, a 26.97% decrease from a year earlier, with the FY2025 full-year figure at $15.0 million, down 8.74% from the prior year.
  • Other Non-Current Assets fell to $11.3 million in Q1 2026 per AAWH's latest filing, from $15.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $25.7 million in Q1 2024 and bottomed at $11.3 million in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $19.3 million (2022), against an average of $18.4 million.
  • Across the five-year window, Other Non-Current Assets jumped 31.1% in 2024 and sank 39.76% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $19.3 million in 2022, then increased by 19.59% to $23.1 million in 2023, then slipped by 28.77% to $16.4 million in 2024, then declined by 8.74% to $15.0 million in 2025, then fell by 24.54% to $11.3 million in 2026.
  • Per Business Quant, the three latest AAWH Other Non-Current Assets figures stand at $11.3 million (Q1 2026), $15.0 million (Q4 2025), and $15.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn 11.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.31 Mn
Dec 31, 2025 14.99 Mn
Sep 30, 2025 15.34 Mn
Jun 30, 2025 15.37 Mn
Mar 31, 2025 15.49 Mn
Dec 31, 2024 16.43 Mn
Sep 30, 2024 18.24 Mn
Jun 30, 2024 19.89 Mn
Mar 31, 2024 25.71 Mn
Dec 31, 2023 23.06 Mn
Sep 30, 2023 19.77 Mn
Jun 30, 2023 19.95 Mn
Mar 31, 2023 19.61 Mn
Dec 31, 2022 19.28 Mn
Sep 30, 2022 18.84 Mn
Jun 30, 2022 19.93 Mn
Mar 31, 2022 19.93 Mn
Dec 31, 2021 19.57 Mn
Sep 30, 2021 19.76 Mn
Jun 30, 2021 21.84 Mn